Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Papi

Showing results (201-210 of 428) with videos related to

Pageof 43
Sort By:
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 10, 2015
Biomarkers of oxidative-stress and inflammation in exhaled breath condensate from hospital cleanersEnrico Casimirri, Mariarita Stendardo, Melissa Bonci, et al.
The Journal of Biological Chemistry|August 6, 2008
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cellsAlberto Papi, Marco Contoli, Pierluigi Gasparini, et al.
Pulmonary Pharmacology & Therapeutics|November 14, 2012
Project PriMo: sharing principles and practices of bronchodilator therapy monitoring in COPD: a consensus initiative for optimizing therapeutic appropriateness among Italian specialistsMario Cazzola, Vito Brusasco, Stefano Centanni, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2010
A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor familyFrancesca Polverino, Simonetta Baraldo, Erica Bazzan, et al.
Chest|July 25, 2007
Matrix metalloproteinase-2 protein in lung periphery is related to COPD progressionSimonetta Baraldo, Erica Bazzan, Maria Elena Zanin, et al.
The Journal of Allergy and Clinical Immunology|March 16, 2010
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-upMarco Contoli, Simonetta Baraldo, Brunilda Marku, et al.
ESC Heart Failure|November 10, 2021
Phenotypic heterogeneity of COVID-19 pneumonia: clinical and pathophysiological relevance of the vascular phenotypeMatteo Bertini, Emanuele D'Aniello, Luca Di Ienno, et al.
BMC Pulmonary Medicine|November 10, 2022
Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1 year follow up studyGaetano Scaramuzzo, Luca Ronzoni, Gianluca Campo, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|November 29, 2017
Harmonizing the Nomenclature for Therapeutic Aerosol Particle Size: A ProposalElizabeth V Hillyer, David B Price, Henry Chrystyn, et al.
The European Respiratory Journal|November 1, 2014
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPDAndrea Rossi, Thys van der Molen, Ricardo del Olmo, et al.
Pageof 43

Showing results (201-210 of 428) with videos related to

Sort By:
Pageof 43
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 10, 2015
Biomarkers of oxidative-stress and inflammation in exhaled breath condensate from hospital cleanersEnrico Casimirri, Mariarita Stendardo, Melissa Bonci, et al.
The Journal of Biological Chemistry|August 6, 2008
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cellsAlberto Papi, Marco Contoli, Pierluigi Gasparini, et al.
Pulmonary Pharmacology & Therapeutics|November 14, 2012
Project PriMo: sharing principles and practices of bronchodilator therapy monitoring in COPD: a consensus initiative for optimizing therapeutic appropriateness among Italian specialistsMario Cazzola, Vito Brusasco, Stefano Centanni, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2010
A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor familyFrancesca Polverino, Simonetta Baraldo, Erica Bazzan, et al.
Chest|July 25, 2007
Matrix metalloproteinase-2 protein in lung periphery is related to COPD progressionSimonetta Baraldo, Erica Bazzan, Maria Elena Zanin, et al.
The Journal of Allergy and Clinical Immunology|March 16, 2010
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-upMarco Contoli, Simonetta Baraldo, Brunilda Marku, et al.
ESC Heart Failure|November 10, 2021
Phenotypic heterogeneity of COVID-19 pneumonia: clinical and pathophysiological relevance of the vascular phenotypeMatteo Bertini, Emanuele D'Aniello, Luca Di Ienno, et al.
BMC Pulmonary Medicine|November 10, 2022
Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1 year follow up studyGaetano Scaramuzzo, Luca Ronzoni, Gianluca Campo, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|November 29, 2017
Harmonizing the Nomenclature for Therapeutic Aerosol Particle Size: A ProposalElizabeth V Hillyer, David B Price, Henry Chrystyn, et al.
The European Respiratory Journal|November 1, 2014
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPDAndrea Rossi, Thys van der Molen, Ricardo del Olmo, et al.
Pageof 43